Breaking News
Sort by:
Top Post
Roche’s Tecentriq Plus Avastin Reduced Risk of Cancer Returning in People with Certain Types of Adjuvant Liver Cancer in a Phase III Study
Roche has announced new data from the Phase III IMbrave050 study that show Tecentriq (atezolizumab) […]
New Chemotherapy-free Treatment for Bowel Cancer Made Available in Scotland
The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug pembrolizumab (Keytruda) for some adults with bowel cancer that’s […]
NHS Launches World’s Largest Trial of Cancer Blood Test
The NHS will today launch the world’s largest trial of a revolutionary new blood test […]
Elixiron Immunotherapeutics Announces Closing of $27 Million Series A-1 Financing Round to Progress Alzheimer's Disease and Vitiligo Clinical-Stage Assets
Elixiron Immunotherapeutics, Inc., a privately held company developing therapeutics for cancer, neurological diseases and inflammatory […]
Roche Receives FDA Approval for First Companion Diagnostic to Identify dMMR Solid Tumour Patients Eligible for Anti-PD-1 Immunotherapy
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval […]
Immunitas Therapeutics Completes $58 Million Series B Financing to Advance Pipeline and Expand Single Cell Analysis Drug Development Platform
Immunitas Therapeutics (“Immunitas”), a single cell genomics-based therapeutics company, today announced the completion of a $58 […]
Gracell Biotechnologies Signs Exclusive License Agreement with FutureGen Biopharm to Develop Engineered Immune Cell Therapies Targeting Claudin 18.2 in Solid Tumors
Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to developing highly […]
New Drug Combo for Advanced Breast Cancer Approved for NHS in England
The National Institute of Health and Care Excellence (NICE) has approved the use of a […]
NUHS Embarks on Holomedicine Research in Singapore, Using Mixed Reality (MR) Technology to Enhance Diagnosis, Education and Patient Care
To be able to literally “see inside” a patient’s skull and identify the location of […]
New Option to Treat Advanced Oesophageal Cancer Approved for NHS in Scotland
The Scottish Medicines Consortium (SMC) has approved the immunotherapy drug nivolumab (Opdivo) for patients with a type […]
Micronoma Wins Bio-IT World Innovative Practices Award
Micronoma, the first cancer detection biotech company to diagnose cancer at an early stage with microbiome-driven […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more